1. Grün B, Krautter S, Riedel K-D, Mikus G (2009) Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole. Br J Clin Pharmacol 68:712–720
2. Hajda JP, Jahnchen E, Oie S, Trenk D (2002) Sequential first-pass metabolism of nortilidine: the active metabolite of the synthetic opioid drug tilidine. J Clin Pharmacol 42:1257–1261
3. Hesse LM, von Moltke LL, Shader RI, Greenblatt DJ (2001) Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion. Drug Metab Dispos 29:100–102
4. International Narcotics Board Control (INCB) (2011) Estimated world requirements of narcotic drugs in grams for 2011. http://www.incb.org/pdf/e/estim/2011/EstFeb11.pdf . Accessed 05 Feb 2011
5. Obach RS (1997) Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. Drug Metab Dispos 25:1359–1369